CGEM
Cullinan Oncology LLC
NASDAQ: CGEM · HEALTHCARE · BIOTECHNOLOGY
$12.85
+0.31% today
Updated 2026-04-29
Market cap
$837.68M
P/E ratio
—
P/S ratio
25.86x
EPS (TTM)
$-3.36
Dividend yield
—
52W range
$6 – $17
Volume
0.8M
Cullinan Oncology LLC (CGEM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $18.94M | $18.94M | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | +0.0% | -100.0% | — | — | — |
| Cost of revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $43000.00 | $70000.00 | $62000.00 | $53000.00 | $93000.00 | $310000.00 | $306000.00 | $311000.00 |
| Gross profit | — | $0.00 | $0.00 | $0.00 | $0.00 | $-43000.00 | $-70000.00 | $-62000.00 | $18.94M | $-93000.00 | $-310000.00 | $-306000.00 | $-311000.00 |
| Gross margin | — | — | — | — | — | — | — | -0.3% | 100.0% | — | — | — | — |
| R&D | — | — | $8702.00 | — | — | $9.58M | $16.79M | $43.21M | $57.75M | $91.95M | $148.16M | $142.90M | $187.40M |
| SG&A | $175000.00 | $124645.00 | $118161.00 | $95438.00 | $197397.00 | $5.00M | $5.48M | $17.12M | $29.15M | $40.19M | $42.49M | $52.82M | $54.25M |
| Operating income | — | $-699034.00 | $-128794.00 | $-95438.00 | $-197397.00 | $-14.59M | $-22.27M | $-60.34M | $-67.95M | $144.65M | $-191.09M | $-196.92M | $-241.65M |
| Operating margin | — | — | — | — | — | — | — | -318.5% | -358.7% | — | — | — | — |
| EBITDA | — | — | — | — | — | $-14.54M | $-22.20M | $-60.27M | $-67.90M | $-132.04M | $-190.34M | $-167.15M | $-241.65M |
| EBITDA margin | — | — | — | — | — | — | — | -318.2% | -358.4% | — | — | — | — |
| EBIT | — | $-699034.00 | $-128794.00 | $-95438.00 | $-197397.00 | $-14.59M | $-22.27M | $-60.34M | $-67.95M | $-132.14M | $-190.65M | $-167.46M | $-241.96M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $888000.00 | $65.45M | $562.35M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | — | $-704663.00 | $-130537.00 | $-109510.00 | $-316703.00 | $-14.19M | $-20.04M | $-50.85M | $-65.04M | $111.21M | $-153.16M | $-167.38M | $-219.88M |
| Net income growth (YoY) | — | — | +81.5% | +16.1% | -189.2% | -4380.2% | -41.2% | -153.8% | -27.9% | +271.0% | -237.7% | -9.3% | -31.4% |
| Profit margin | — | — | — | — | — | — | — | -268.4% | -343.3% | — | — | — | — |